BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16448886)

  • 1. Determinants of sustained uncontrolled blood pressure in a national cohort of persons with diabetes.
    Greenberg JD; Tiwari A; Rajan M; Miller D; Natarajan S; Pogach L
    Am J Hypertens; 2006 Feb; 19(2):161-9. PubMed ID: 16448886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics.
    Duggirala MK; Cuddihy RM; Cuddihy MT; Naessens JM; Cha SS; Mandrekar JN; Leibson CL
    Am J Hypertens; 2005 Jun; 18(6):833-8. PubMed ID: 15925744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncontrolled hypertension based on morning and evening home blood pressure measurements from the J-HOME study.
    Obara T; Ito K; Ohkubo T; Shibamiya T; Shinki T; Nakashita M; Hara A; Metoki H; Inoue R; Asayama K; Kikuya M; Mano N; Imai Y;
    Hypertens Res; 2009 Dec; 32(12):1072-8. PubMed ID: 19779486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension control: how well are we doing?
    Borzecki AM; Wong AT; Hickey EC; Ash AS; Berlowitz DR
    Arch Intern Med; 2003 Dec 8-22; 163(22):2705-11. PubMed ID: 14662624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States.
    Ezzati M; Oza S; Danaei G; Murray CJ
    Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
    Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
    J Am Coll Cardiol; 2005 Aug; 46(3):508-15. PubMed ID: 16053966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
    McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH
    Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of masked hypertension in treated hypertensive patients with type 2 diabetes mellitus.
    Alsuwaida A; Parkes R; So J; Feig D; Logan A
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):326-37. PubMed ID: 16970252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.
    Johnson ML; Pietz K; Battleman DS; Beyth RJ
    Am J Manag Care; 2004 Dec; 10(12):926-32. PubMed ID: 15617368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for uncontrolled hypertension in Italy.
    Degli Esposti E; Di Martino M; Sturani A; Russo P; Dradi C; Falcinelli S; Buda S
    J Hum Hypertens; 2004 Mar; 18(3):207-13. PubMed ID: 14973516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.
    Ho PM; Magid DJ; Shetterly SM; Olson KL; Peterson PN; Masoudi FA; Rumsfeld JS
    Arch Intern Med; 2008 Feb; 168(3):271-6. PubMed ID: 18268167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure control and comorbidity in a nephrology clinic.
    Triolo L; Cattaruzza MS; Sicoli R; Ansali F; Malaguti M; Osborn J; Biagini M
    J Nephrol; 2004; 17(6):808-12. PubMed ID: 15593055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988-2004.
    Suh DC; Kim CM; Choi IS; Plauschinat CA; Barone JA
    J Hypertens; 2009 Sep; 27(9):1908-16. PubMed ID: 19491704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus.
    Godley PJ; Maue SK; Farrelly EW; Frech F
    Am J Manag Care; 2005 Apr; 11(4):206-10. PubMed ID: 15839181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls in blood pressure measurement in daily practice.
    Houweling ST; Kleefstra N; Lutgers HL; Groenier KH; Meyboom-de Jong B; Bilo HJ
    Fam Pract; 2006 Feb; 23(1):20-7. PubMed ID: 16332947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide programme.
    Karwalajtys T; Kaczorowski J; Hutchison B; Myers MG; Sullivan SM; Chambers LW; Lohfeld L
    J Hum Hypertens; 2009 Sep; 23(9):585-9. PubMed ID: 19158822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.